A new cell counting method to evaluate anti-tumor compound activity

Asian Pac J Cancer Prev. 2014;15(8):3397-401. doi: 10.7314/apjcp.2014.15.8.3397.

Abstract

Determining cell quantity is a common problem in cytology research and anti-tumor drug development. A simple and low-cost method was developed to determine monolayer and adherent-growth cell quantities. The cell nucleus is located in the cytoplasm, and is independent. Thus, the nucleus cannot make contact even if the cell density is heavy. This phenomenon is the foundation of accurate cell-nucleus recognition. The cell nucleus is easily recognizable in images after fluorescent staining because it is independent. A one-to-one relationship exists between the nucleus and the cell; therefore, this method can be used to determine the quantity of proliferating cells. Results indicated that the activity of the histone deacetylase inhibitor Z1 was effective after this method was used. The nude-mouse xenograft model also revealed the potent anti-tumor activity of Z1. This research presents a new anti-tumor-drug evaluation method.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis / drug effects*
  • Cell Count / methods
  • Cell Cycle / drug effects
  • Cell Line, Tumor
  • Cell Nucleus*
  • Cell Proliferation / drug effects
  • Cell Survival / drug effects
  • Drug Screening Assays, Antitumor / methods
  • HCT116 Cells
  • HeLa Cells
  • Histone Deacetylase Inhibitors / pharmacology*
  • Humans
  • Hydroxamic Acids / pharmacology
  • Mice
  • Mice, Nude
  • Vorinostat
  • Xenograft Model Antitumor Assays / methods*

Substances

  • Histone Deacetylase Inhibitors
  • Hydroxamic Acids
  • Vorinostat